The enzyme catechol-o-methyltransferase (COMT) transfers a methyl group from adenosylmethionine to catecholamines including the neurotransmitters dopamine, epinephrine and norepinephrine. This methylation results in the degradation of catecholamines. The involvement of the COMT gene in the metabolic pathway of these neurotransmitters has made it an attractive candidate gene for many psychiatric disorders. In this article, we reported our study of association of COMT with schizophrenia in Irish families with a high density of schizophrenia. Three single nucleotide polymorphisms (SNPs) were genotyped for the 274 such families and within-family transmission disequilibrium tests were performed. SNP rs4680, which is the functional Val/Met polymorphism, showed modest association with the disease by the TRANSMIT, FBAT and PDT programs, while the other two SNPs were negative. These SNPs showed lower level of LDs with each other in the Irish subjects than in Ashkenazi Jews. Haplotype analysis indicated that a haplotype, haplotype A-G-A for SNPs rs737865-rs4680-rs165599, was preferentially transmitted to the affected subjects. This was different from the reported G-G-G haplotype found in Ashkenazi Jews, but both haplotypes shared the Val allele. We concluded that COMT gene is associated with schizophrenia and carries a small but significant risk to the susceptibility in the Irish subjects. Molecular Psychiatry (2004) 9, 962-967.
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The COMT gene is located on chromosome 22q11, a region that showed positive results in some linkage studies [2] [3] [4] but was negative in others. [5] [6] [7] [8] The region is also associated with the velocardiofacial syndrome (VCFS), 9 a genetic disorder characterized by cleft palate, heart defects and characteristic facial appearance. Studies have shown that patients with VCFS are at increased risk for schizophrenia. 10 While the cause of the VCFS is still unknown, many VCFS patients have a microdeletion in the chromosome 22q11 region. This implies that the deletion may contain one or more susceptibility genes for schizophrenia. There are many polymorphisms in COMT gene (http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?locusId ¼ 1312), one of which, rs4680, that changes a Val codon to a Met codon (Val/Met) at the 158 th position of the M-form of the gene, has been studied widely for its association with schizophrenia [11] [12] [13] [14] [15] [16] [17] and other psychiatric disorders. [18] [19] [20] [21] [22] In association study with schizophrenia, the Val/Met polymorphism has produced inconsistent results. Earlier studies, using population samples, suggested that the Met allele was associated with schizophrenia. 14, 23 More recently studies indicated that the Val allele was associated with the disease. 16, 24 We are aware of six family-based association studies for the COMT gene, two of which used subjects of European descent and found that the Val allele was preferentially transmitted to the affected offspring. 11, 13 The other four studies [25] [26] [27] [28] used Asian subjects and produced inconsistent results. The functional change of the Val/Met polymorphism alters the stability of the enzyme, 29 and it was suggested that this change was linked to poor performance of prefrontal cortex in schizophrenia patients when confronted with cognitively demanding tasks. 11 In most of these studies, the Val/Met polymorphism was the only variant tested. A recent study extended the study of this gene to other polymorphisms, and more SNPs were identified to be associated with schizophrenia. 16 More importantly, a haplotype defined by these associated SNPs showed highly significant association with this disease. In an expression study, Bray et al 30 demonstrated that the haplotype associated with schizophrenia had lower expression than other haplotypes in human brain.
The Irish study of high-density schizophrenia families (ISHDSF) is a well-studied sample for schizophrenia. [31] [32] [33] Genome scan studies of the sample produced several linkage peaks at 6p22, 5q21-31, 8p and 10p. However, no linkage signal was observed at 22q11, where the COMT gene is located. In light of the recent finding of highly significant haplotype in the COMT gene, 16 we decided to replicate the study using our ISHDSF sample. We tested the three SNPs that defined the most significant haplotype in the Ashkenazi study. 16 The aim was to attempt to replicate the Ashkenazi study and to discover susceptible haplotypes in the ISHDSF subjects.
Methods and materials

The subjects
The ISHDSF was a sample collected in the North Ireland and the Republic of Ireland. Phenotypes were assessed using DSM-III-R. 34 The diagnosis was constructed into a hierarchy of 10 categories reflecting the probable genetic relationship of these syndromes to classical schizophrenia. This hierarchy contains three definitions of affection: (i) Narrow-categories D1 and D2, or 'core schizophrenia'-schizophrenia, poor-outcome schizoaffective disorder and simple schizophrenia; (ii) Intermediate-categories D1-D5, or a narrow definition of the schizophrenia spectrum, adding to the narrow definition schizotypal personality disorder, schizophreniform disorder, delusional disorder, atypical psychosis and good-outcome schizoaffective disorder; (iii) Broad-categories D1-D8, including all disorders which significantly aggregated in relatives of schizophrenic probands in the Roscommon Family Study 35 and adding to the intermediate definition mood incongruent and mood congruent psychotic affective illness, and paranoid, avoidant and schizoid personality disorder. The final inclusion criteria for pedigrees in the ISHDSF sample required two or more first-second-or third-degree relatives with a diagnosis of D1-D5, one or more of whom had a D1-D2 diagnosis. This study used 267 pedigrees containing 1337 subjects. Of these families, 515 subjects were classified as core schizophrenia (D1 and D2), averaging 1.9 subjects/pedigree. There were 634 and 686 subjects with D1-D5 and D1-D8 diagnosis respectively, accounting for 47 and 51% of the total genotyped subjects.
SNP selection and genotyping
This was a replication study aiming at direct repeating the SNPs typed in a previous study, 16 so only those SNPs that were associated with the disease in that study were used. These were rs737865, rs4680-which is the Val/Met polymorphism-and rs165599. We used the FP-TDI protocol for SNP typing. 36 Briefly, PCRs were performed with 7.5 ng genomic DNA, 100 nM of each PCR primer, 250 mM dNTPs, 10 mM Tris-HCl, pH 8.0, 2.5 mM MgCl 2 and 0.5 Unit of HotMaster Taq DNA polymerase (Eppendorf AG, Hamburg, Germany). Thermal cycling conditions for PCR were the following: 951C for 3 min, followed by 10 cycles of 951C for 30 s; 751C for 5 s, ramping to 651C at À0.11C/s; 651C for 45 s, followed by 30 cycles of 951C for 30 s; 601C for 45 s, followed by a final extension at 721C for 5 min. PCR products were cleaned up with 1 Unit of shrimp alkaline phosphatase and 0.1 Unit of Escherichia coli exonuclease I (371C for 1 h). The enzymes were then inactivated at 951C for 15 min. The single-base extension was performed with the FP-TDI kits from Perkin-Elmer Corporation (Boston, MA, USA). After the reaction samples were read by a fluorescence polarization plate reader (Analyst, made by Molecular Dynamics Corporation, Sunnyvale, CA, USA) and genotypes were scored using a Microsoft Excel Template developed in our lab. 37 PCR primer pairs for rs737865, rs4680 and rs165599 were TCAGGCTTGGAGGGT-CACTTTA and TTCCCTGCAAGAGAGAGGCTGCT; TGCTGGAGCTGGGGGCCTACT and GGTTTTCAGT GAACGTGGTGTGAAC; and TTGGGCACCAAACATT CAAAGCTC and TTCCCTGCAAGAGAGAGGCTGCT respectively. Extension primers for rs737865, rs4680 and rs165599 were AAAAAGCAACAGGACACAA AAA, ATGGTGGATTTCGCTGGC and TCCTCTTCGT TTCCCAGGC.
Statistical analyses
Association of genotypes and diagnoses was analyzed by TRANSMIT, 38, 39 FBAT 40, 41 and PDT 42 programs. These programs analyze association using transmission disequilibrium test, but each has different features. TRANSMIT tests if an allele is preferentially transmitted to the affected offspring. It does not use information from discordant sib pairs. FBAT emphasizes the comparison between sib pairs. PDT compares both vertical and horizontal disequilibrium. As we were explicitly attempting to replicate prior positive findings, P-values reported were not corrected for multiple testing. Haplotypes were constructed by the SIMWALK2 program. 43 Haplotype associations were performed by first coding the haplotypes into alleles and then testing association using TRANSMIT or other programs. Linkage disequilibrium (LD) was calculated based on the haplotypes reconstructed by the SIMWAlK2 program.
Results
Single marker association
The results of our single marker analysis were summarized in Table 1 . SNP rs4680, which is the Val/Met polymorphism, showed modest association in all three analyses. The Val allele, or allele G, was overtransmitted to affected offspring. The three programs were used because they utilize family information in different ways and have different underlying statistical assumptions. Although their results were certainly not independent, the consistent results obtained from these three distinct methods, to some degree, increases confidence in the validity of the results. We also noticed that the signal of association becomes stronger as the definition of affections broadened (from D2 to D8). When allele frequencies at rs4680 were compared with that of Shifman et al's report, 16 no significant difference was observed (for the G or Val allele, ISDHSF ¼ 0.525; Ashkenazi Jews, control ¼ 0.515, affected ¼ 0.546).
For the other two SNPs, rs737865 and rs165599, no association signals were observed. SNP rs165599, which was the most significant marker in the Shifman et al's report, had P-values from 0.49 to 0.98 by different methods (Table 1, column 3) . In the ISHDSF, the frequency in founders for the G allele was 0.350, which was close to that of the controls in their study (0.369), but was different from that of the cases (0.433). For rs737865, which had P-values from 0.37 to 0.90, the difference in allele frequency between the two samples was even greater, with ISHDSF ¼ 0.234 (the G allele), Ashkenazi control ¼ 0.398, Ashkenazi cases ¼ 0.453.
LDs between the SNPs
We also wished to examine whether the LD structure of the SNPs differed in the two samples. To investigate this, we reconstructed the three marker haplotypes for the ISHDSF subjects using , we observed 0.38 and 0.07, respectively. In a different study with 60 subjects of undisclosed ethnicity, 30 the LDs between these markers fell in between those seen in our sample and that of the Ashkenazi subjects: rs737865-rs4680,
The LD between rs737865 and rs165599 in ISHDSF is weaker as expected, D 0 ¼ 0.2, r 2 ¼ 0.03, since rs4680 is located between rs737865 and rs165599. Despite the difference in levels of LD, the trends observed in this study was similar to that of Bray et al and Shifman et al, that is the LD between rs737865 and rs4680 was stronger than that between rs4680 and rs165599, despite the distance between the former being four times greater than between the latter (about 20 vs 5 kb).
Haplotype association
One of the most important findings in the study of Shifman et al was a highly significant G-G-G haplotype for rs737865-rs4680-rs165599. For comparison, we constructed three marker haplotypes using SIMWALK2 program. We then coded the haplotypes as alleles 1-8 and ran the haplotype association through the TRANSMIT, FBAT and PDT programs ( Table 2) . Global results were significant with PDT (P ¼ 0.009 at D8 category), at a trend level with FBAT, and nonsignificant with TRANSMIT. With all three programs, the P values became more significant with broader definitions of the schizophrenia spectrum. When individual haplotypes were examined, haplotype 1.1.1 (A-G-A for rs737865-rs4680-rs165599) showed significant association with two of the three programs (FBAT, P ¼ 0.0027; PDT, P ¼ 0.0052). With the D8 category, the odds ratio of this haplotype was 1.3 (195 transmitted, 149 untransmitted). Haplotype 1.2.1 (A-A-A), which was the most abundant haplotype in our sample, with a frequency of 35.7%, was preferentially transmitted to unaffected subjects. The most significant haplotype (G-G-G) implicated in the Shifman et al's study had a frequency of 9.7% in our ISHDSF sample and was undertransmitted to affected individuals (for D8 category, TRANSMIT, P ¼ 0.109; FBAT, P ¼ 0.014; and PDT, P ¼ 0.081, Table  2 ). In contrast to the results of our study, in the Ashkenazi subjects the G-G-G haplotype was the second most abundant haplotype (27.8% in cases and 21.9% in controls).
Discussion
The COMT gene as a candidate for schizophrenia has been studied widely, using both case-control and family designs. Most case/control studies examined only the functional Val/Met polymorphism. These studies have produced inconsistent and even conflicting results. 12, 16, 24 While two case/control studies indicated that the Met allele was a liability allele, 14, 23 two other more recent studies found that the Val allele that was associated with disease. 16, 24 Many other studies failed to produce significant results. 12, 44, 45 As noted by others, negative reports with a small sample size are inconclusive because they may lack the necessary power to detect small effects. For case/ control studies, in addition to sample size, population admixtures could obscure the results. While familybased studies are less susceptible to population admixture, ethnicity of the subjects is potentially an important issue. In contrast to studies using Asian subjects, all family-based studies 11, 33 using subjects of European decent, including this study (which has the largest sample size), arrived at same conclusion that the Val allele was a small but consistent risk factor for schizophrenia. In this study, we found a modest odds ratio of 1.3. Association has also been reported recently for DTNBP1 33 gene in the Irish families. We have performed preliminary stratification analysis between the COMT and DTNBP1 genes and no obvious interactions are found. We plan to carry out more thorough analysis and report any potential interactions separately.
The ISHDSF subjects showed a different LD structure across these markers than did the Ashkenazi sample. These differences most likely reflect different histories of the samples. Given that the Ashkenazi Jews had experienced a bottleneck in their evolution, and founder effects were significant, 46 it would not be a surprise to find stronger LDs in that sample. Owing to differences of LD structures between the ISHDSF and Ashkenazi subjects, we found different haplotypes associated with disease in the two samples. But we were surprised that the high-risk haplotype in the Ashkenazi sample was actually undertransmitted to affected individuals in our sample, despite both haplotypes having the Val allele.
In conclusion, this study provided supporting evidence that the COMT gene potentially associated with schizophrenia and, specifically, the Val allele might carry a small increase in disease susceptibility. This was consistent with previous family studies. However, we were unable to confirm the association of rs165599 and rs737865. We also failed to replicate the association of the G-G-G haplotype observed in the Ashkenazi population. In our haplotype analysis, instead, we found that the A-G-A haplotype had modest association with the disease. Detailed examination of LD and haplotype structures indicated that the structures in the ISHDSF subjects were very different from that of the Ashkenazi Jews. We attributed the difference to varying evolutionary histories of these two populations. 
